Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Adial Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 21 | 24 | +3 |
| Shares | 1.28M | 1.34M | +52.4K (+4.1%) |
| Value | $5.50M | $3.61M | −$1.90M (−34.5%) |
New holders (5)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 19,526 | $53.0K | 0.00% |
| Susquehanna International Group, LLP | 12,192 | $33.0K | 0.00% |
| Group One Trading, L.P. | 6,200 | $17.0K | 0.00% |
| High Net Worth Advisory Group LLC | 1,000 | $3.00K | 0.00% |
| Cornerstone Advisory, LLC | 25 | $0 | 0.00% |
Sold out (2)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| NorthRock Partners, LLC | 10,000 | $43.0K |
| Tower Research Capital LLC (TRC) | 95 | $0 |